Hugh M Cole Insider Trading $ARIA ARIAD PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hugh M Cole.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hugh M Cole. Hugh M Cole is SVP, Chief Business Officer in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Chief Business Officer in Jounce Therapeutics, Inc. ($JNCE).
Hugh M Cole in ARIAD PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Hugh M Cole: SVP, Chief Business Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 16 2017
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Hugh M Cole in ARIAD PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARIA, CATB, JNCE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | D | 0.00 | 9,788 | 0 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | D | 0.00 | 64,733 | 0 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | D | 6.51 | 78,000 | 507,780 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | D | 6.40 | 100,000 | 640,000 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Sell | D | 0.00 | 42,834 | 0 | 0 | 42.8 K to 0 (-100.00 %) |
| Feb 07 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | A | 0.00 | 9,788 | 0 | 9,788 | |
| Feb 07 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
| Feb 07 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | M | 0.00 | 6,667 | 0 | 6,667 | |
| Feb 07 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Payment of Exercise | F | 8.69 | 6,249 | 54,304 | 42,834 | 49.1 K to 42.8 K (-12.73 %) |
| Feb 07 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Buy | M | 0.00 | 6,667 | 0 | 49,083 | 42.4 K to 49.1 K (+15.72 %) |
| Feb 07 2017 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Buy | M | 0.00 | 12,500 | 0 | 42,416 | 29.9 K to 42.4 K (+41.78 %) |
| Jun 29 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | M | 0.00 | 6,666 | 0 | 6,667 | |
| Jun 29 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
| Jun 29 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Sell | S | 7.05 | 6,012 | 42,385 | 29,916 | 35.9 K to 29.9 K (-16.73 %) |
| Jun 29 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Buy | M | 0.00 | 6,666 | 0 | 35,928 | 29.3 K to 35.9 K (+22.78 %) |
| Jun 29 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Buy | M | 0.00 | 12,500 | 0 | 29,262 | 16.8 K to 29.3 K (+74.57 %) |
| May 02 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | M | 0.00 | 17,334 | 0 | 0 | |
| May 02 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Payment of Exercise | F | 7.18 | 5,634 | 40,452 | 16,762 | 22.4 K to 16.8 K (-25.16 %) |
| May 02 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Buy | M | 0.00 | 17,334 | 0 | 22,396 | 5.1 K to 22.4 K (+342.43 %) |
| Mar 18 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | M | 0.00 | 7,500 | 0 | 7,500 | |
| Mar 18 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Mar 18 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Payment of Exercise | F | 6.21 | 2,438 | 15,140 | 5,062 | 7.5 K to 5.1 K (-32.51 %) |
| Mar 18 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Buy | M | 6.21 | 7,500 | 46,575 | 7,500 | 0 to 7.5 K |
| Mar 09 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | A | 0.00 | 23,400 | 0 | 23,400 | |
| Mar 09 2016 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | A | 6.51 | 78,000 | 507,780 | 78,000 | |
| Apr 30 2015 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | A | 0.00 | 52,000 | 0 | 52,000 | |
| Jun 27 2014 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | A | 6.40 | 100,000 | 640,000 | 100,000 | |
| Jun 27 2014 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Jun 27 2014 | ARIA | ARIAD PHARMACEUTIC ... | Cole Hugh M | SVP, Chief Business ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 |
Page: 1